Position in ARGX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$121,800,428
+$10,072,178 QoQ
Shares Held
131,283
-14.2% QoQ
Ownership
0.211%
of shares outstanding
% of Portfolio
31.25%
of 13F equity value
Holder Rank
#36
of 505 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Checkpoint Capital L.P. holds $389,759,659 across 6 Biotechnology names. ARGX ranks #2 (31.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,186,000 | $131,681,580 | |
| 2 | ARGX |
Argenx SE
This page
|
131,283 | $121,800,428 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
410,353 | $76,850,909 | |
| 4 | CYTK |
Cytokinetics Inc
|
475,000 | $40,465,250 | |
| 5 | IRON |
Disc Medicine, Inc.
|
240,125 | $17,562,742 | |
| 6 | TRVI |
Trevi Therapeutics, Inc.
|
75,000 | $1,398,750 |
All Filings in ARGX
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $121,800,428 | 131,283 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $111,728,250 | 153,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $119,414,900 | 142,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $110,634,000 | 150,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $82,670,321 | 149,977 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $68,064,475 | 115,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $56,887,500 | 92,500 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $50,142,400 | 92,500 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $35,327,786 | 82,150 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $32,285,040 | 82,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $26,630,100 | 70,000 | Shares | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||